Annual Lung SPORE Workshop (Abstract Submission)

Filter submissions
75 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Mon, 05/13/2024 - 12:50 Robert Hsu robert.hsu@med.usc.edu 9148153821 Session 2: Health Disparities in Lung Cancer Real-World Molecular Testing Disparities at a Large Academic Institution in Los Angeles

Robert Hsu University of Southern California Norris Comprehensive Cancer Center
  • First Name: Darin
    Last Name: Poei
    Affiliation: University of Southern California
  • First Name: Jacob
    Last Name: Thomas
    Affiliation: University of Southern California Norris Comprehensive Cancer Center
  • First Name: Jorge
    Last Name: Nieva
    Affiliation: University of Southern California Norris Comprehensive Cancer Center
 Abstract_Submission.pdf No
Fri, 03/08/2024 - 18:05 Monique (Presented by Heymach) Nilsson mnilsson@mdanderson.org 7137458407 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Trastuzumab deruxtecan resistance can be mediated by payload resistance or secondary extracellular ERBB2 mutations but sensitivity to HER2 tyrosine kinase inhibitors is maintained John Heymach (Submitted by M. Nilsson) MD Anderson Cancer Center
  • First Name: Xiuning
    Last Name: Le
    Affiliation: MDACC
  • First Name: Junqin
    Last Name: He
    Affiliation: MDACC
  • First Name: Xiaoxing
    Last Name: Yu
    Affiliation: MDACC
  • First Name: Xiaofang
    Last Name: Huo
    Affiliation: UTSW
  • First Name: Ashwani
    Last Name: Kumar
    Affiliation: UTSW
  • First Name: Alissa
    Last Name: Poteete
    Affiliation: MDACC
  • First Name: Qian
    Last Name: Huang
    Affiliation: MDACC
  • First Name: Ralf
    Last Name: Kittler
    Affiliation: UTSW
  • First Name: John
    Last Name: Heymach
    Affiliation: MDACC
 Abstract_Submission.pdf No 2024.5.29 Heymach Lung Spore Enhertu Resistance.jpg
Mon, 03/11/2024 - 14:27 Hyunmin Lee hyunmin.lee@yale.edu 7739800378 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies, Session 6: Cancer Biology LKB1-SIK axis controls SHMT-mediated antioxidant defense in KRAS-mutant lung cancer Hyunmin Lee Yale University
  • First Name: Constantinos
    Last Name: Chronis
    Affiliation: UIC
  • First Name: Kailong
    Last Name: Li
    Affiliation: Peking Univerisity
  • First Name: Brandon
    Last Name: Faubert
    Affiliation: University of Chicago
  • First Name: James
    Last Name: Kim
    Affiliation: UTSW
  • First Name: Jiyeon
    Last Name: Kim
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 06:48 Elliott Brea elliott_brea@dfci.harvard.edu 8479221042 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings Elliott Brea DFCI
  • First Name: Eric
    Last Name: Smith
    Affiliation: DFCI
  • First Name: David
    Last Name: Barbie
    Affiliation: DFCI
  • First Name: Sachiv
    Last Name: Chakravarti
    Affiliation: DFCI
  • First Name: Alexis
    Last Name: Mottram
    Affiliation: DFCI
  • First Name: Prafulla
    Last Name: Gokhale
    Affiliation: DFCI
  • First Name: Ken
    Last Name: Ng
    Affiliation: DFCI
  • First Name: Cloud
    Last Name: Paweletz
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Jänne
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Elena
    Last Name: Ivanova
    Affiliation: DFCI
  • First Name: Ha
    Last Name: Vo
    Affiliation: DFCI
  • First Name: Tran
    Last Name: Thai
    Affiliation: DFCI
  • First Name: Timothy
    Last Name: Haggerty
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 14:46 Austin Draycott austin.draycott@yale.edu 3475969754 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Dihydrouridine synthase 2 sustains levels of tRNACys to inhibit ferroptosis in lung cancer Austin Draycott Yale University
  • First Name: Matthew
    Last Name: Wang
    Affiliation: Yale University
  • First Name: Diana
    Last Name: Martínez Saucedo
    Affiliation: Yale University
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Yale University
  • First Name: Wendy
    Last Name: Gilbert
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:59 Mustafa Al-Dulaimi mustafa_al-dulaimi@dfci.harvard.edu 12087180181 Session 6: Cancer Biology CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC) Mustafa Al-Dulaimi DFCI
  • First Name: Antja-Voy
    Last Name: Hartley
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Matthew
    Last Name: Booker
    Affiliation: DFCI
  • First Name: Nathanael
    Last Name: Gray
    Affiliation: Stanford Cancer Institute
  • First Name: Michael
    Last Name: Tolsturokov
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Janne
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 14:39 Tikvah Hayes TKHayes@mednet.ucla.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Deep Mutational Scanning of EGFR Reveals Potential Domain-Specific TKI Sensitivities in Lung Cancer Tikvah Hayes UCLA Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 14:54 Michael Grant michael.grant@yale.edu 2033147088 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Efficacy of afatinib in patients with tumors harboring the uncommon EGFR exon 19 deletion, L747_A750delinsP: a pooled analysis Michael Grant Yale University
  • First Name: Fernando
    Last Name: de Miguel
    Affiliation: Yale University
  • First Name: Michael
    Last Name: Kane
    Affiliation: Yale University
  • First Name: Yong
    Last Name: Kong
    Affiliation: Yale University
  • First Name: Jieling
    Last Name: Miao
    Affiliation: Fred Hutchinson Cancer Research Center
  • First Name: Mary
    Last Name: Redman
    Affiliation: Fred Hutchinson Cancer Research Center
  • First Name: Zenta
    Last Name: Walther
    Affiliation: Yale University
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale University
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:33 Darin Dolezal darin.dolezal@yale.edu 203-584-4276 Session 6: Cancer Biology Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer Darin Dolezal Yale School of Medicine - Department of Pathology
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal Estapé
    Affiliation: Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale School of Medicine
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale School of Medicine
 Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:21 Hari Shankar Sunil harishankar.sunil@utsouthwestern.edu 9727302166 Session 3: Immuno-oncology, Session 6: Cancer Biology Transmembrane Serine Protease TMPRSS11B promotes tumorigenesis in lung squamous cell carcinoma through enhanced lactate export and modulation of the tumor microenvironment Hari Shankar Sunil UT Southwestern Medical Center
  • First Name: Barrett
    Last Name: Updegraff
    Affiliation: Seagen
  • First Name: Jingfei
    Last Name: Zhu
    Affiliation: UT Southwestern Medical Center
  • First Name: Lisa
    Last Name: Thomas
    Affiliation: UT Southwestern Medical Center
  • First Name: Anthony
    Last Name: Grichuk
    Affiliation: UT Southwestern Medical Center
  • First Name: Bret
    Last Name: Evers
    Affiliation: UT Southwestern Medical Center
  • First Name: Jean
    Last Name: Clemenceau
    Affiliation: Mayo Clinic
  • First Name: Isabel
    Last Name: Barnfather
    Affiliation: Mayo Clinic
  • First Name: John
    Last Name: Minna
    Affiliation: UT Southwestern Medical Center
  • First Name: Ralph
    Last Name: Deberardinis
    Affiliation: UT Southwestern Medical Center
  • First Name: Trudy
    Last Name: Oliver
    Affiliation: Duke University
  • First Name: Tae Hyun
    Last Name: Hwang
    Affiliation: Mayo Clinic
  • First Name: Jinming
    Last Name: Gao
    Affiliation: UT Southwestern Medical Center
  • First Name: Kathryn
    Last Name: O'Donnell
    Affiliation: UT Southwestern Medical Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:12 Esra Akbay esra.akbay@utsouthwestern.edu 2146484159 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Kras G12D inhibition causes tumor regression and synergizes with immune checkpoint blockade in immunogenic lung cancer models Esra Akbay UT Southwestern Medical Center Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:03 Jensen Abascal jensenabascal@g.ucla.edu (310) 266-8937 Session 3: Immuno-oncology In situ vaccination with Flt3l gene modified CD103+ type 1 conventional dendritic cells synergizes with anti-PD-1 checkpoint blockade in murine models of non-small cell lung cancer Jensen Abascal Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Raymond
    Last Name: Lim
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA.
  • First Name: Ramin
    Last Name: Salehi Rad
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. VA Greater Los Angeles Health Care Center, Los Angeles, California
  • First Name: Zhe
    Last Name: Jing
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Michael
    Last Name: Oh
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA;
  • First Name: William
    Last Name: Crosson
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA.
  • First Name: Bitta
    Last Name: Kahangi
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Edgar
    Last Name: Perez Reyes
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA.
  • First Name: Camelia
    Last Name: Dumitras
    Affiliation: Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Diana
    Last Name: Reyimjan
    Affiliation: Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Linh
    Last Name: Tran
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Manash
    Last Name: Paul
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Kostyantyn
    Last Name: Krysan
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Bin
    Last Name: Liu
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • First Name: Steven
    Last Name: Dubinett
    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Department of Pathology and Laboratory Medicine, UCLA. Jonsson Comprehensive Cancer Center, Los Angeles, California. VA Greater Los Angeles Health Care Center, Los Angeles, Ca
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 12:23 Savannah Kandigian savannah.kandigian@yale.edu Session 6: Cancer Biology Molecular and histological characterization of NSCLC progression to leptomeningeal metastasis with comorbid intraparenchymal disease Savannah Kandigian Department of Pathology, Yale School of Medicine
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Darin
    Last Name: Dolezal
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Tang
    Last Name: Tang
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Department of Medical Oncology, Yale School of Medicine
  • First Name: Sally
    Last Name: Adua
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Stephanie
    Last Name: Cheok
    Affiliation: Department of Neurological Surgery, University of Southern California
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Nicholas
    Last Name: Blondin
    Affiliation: Department of Neurology, Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Department of Neurosurgery, Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Department of Pathology, Yale School of Medicine
Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 12:01 Mark Lee mark.n.lee@yale.edu 6178200262 Session 3: Immuno-oncology The antigen specificity of tumor-targeting T cells in non-small cell lung cancer Berkay Yahsi Yale Department of Laboratory Medicine
  • First Name: Benjamin
    Last Name: Lu
    Affiliation: Yale Cancer Center
  • First Name: Jianlei
    Last Name: Gu
    Affiliation: Yale School of Public Health
  • First Name: Kalyn
    Last Name: Whitehead
    Affiliation: Yale Department of Laboratory Medicine
  • First Name: Heather
    Last Name: Lazowski
    Affiliation: Yale Cancer Center
  • First Name: Yalai
    Last Name: Bai
    Affiliation: Yale Department of Pathology
  • First Name: David
    Last Name: Rimm
    Affiliation: Yale Department of Pathology
  • First Name: Hongyu
    Last Name: Zhao
    Affiliation: Yale School of Public Health
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Yale Department of Neurosurgery
  • First Name: David
    Last Name: Hafler
    Affiliation: Yale Department of Neurology
  • First Name: Kurt
    Last Name: Schalper
    Affiliation: Yale Department of Pathology
  • First Name: Mark
    Last Name: Lee
    Affiliation: Yale Department of Laboratory Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Tue, 02/20/2024 - 09:01 May-Lucie Meyer may-lucie.meyer@mssm.edu Session 4: Small Cell Lung Cancer, Session 6: Cancer Biology DLL3 expression in early-stage SCLC: comparative analysis of IHC and mRNA ISH May-Lucie Meyer Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
  • First Name: Hui
    Last Name: Yu
    Affiliation: Medical Oncology, University ofColorado Anschutz Campus, Aurora, USA
  • First Name: Zoltan
    Last Name: Lohinai
    Affiliation: OKTPI-Koranyi National Institute, Budapest, Hungary
  • First Name: Grace
    Last Name: van Hyfte
    Affiliation: epartment of Population HealthScience and Policy, Icahn School of Medicine at Mount Sinai, New York, USA
  • First Name: Fred
    Last Name: Hirsch
    Affiliation: Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
 Abstract_Submission.pdf No Approved to be a Poster Presenter DLL3 expression in SCLC Poster.jpeg
Mon, 03/11/2024 - 11:19 Shayna Thomas-Jardin shayna.thomas-jardin@utsouthwestern.edu 2144630651 Session 3: Immuno-oncology The integrated stress response (ISR) pathway coordinately regulates multiple immune checkpoint proteins in lung cancer Shayna Thomas-Jardin Department of Molecular Biology, UT Southwestern Medical Center
  • First Name: Shruthy
    Last Name: Suresh
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Nicole
    Last Name: Novaresi
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Lisa
    Last Name: Thomas
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Cheryl
    Last Name: Lewis
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, UTSW
  • First Name: Chul
    Last Name: Ahn
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, O’Donnell School of Public Health, UTSW
  • First Name: Bret
    Last Name: Evers
    Affiliation: Department of Pathology, UTSW
  • First Name: Luisa Maris
    Last Name: Solis Soto
    Affiliation: Department of Translational Molecular Pathology, UT MD Anderson Cancer Center
  • First Name: Ignacio
    Last Name: Wistuba
    Affiliation: Department of Translational Molecular Pathology, UT MD Anderson Cancer Center
  • First Name: John
    Last Name: Minna
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Therapeutic Oncology Research, Department of Pharmacology, UTSW
  • First Name: Kathryn
    Last Name: O'Donnell
    Affiliation: Dept of Mol Biology, Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Regenerative Science and Medicine, UTSW
 Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 10:17 Kersten Pierre kpier26@emory.edu 8324019591 Session 2: Health Disparities in Lung Cancer, Session 3: Immuno-oncology Communication Issues in Patient/Provider Discussions of Immunotherapy Kersten Pierre Winship Cancer Institute at Emory University
  • First Name: Ayannah
    Last Name: Lang
    Affiliation: Winship Cancer Institute at Emory University
  • First Name: Rebecca
    Last Name: Pentz, PhD
    Affiliation: Winship Cancer Institute at Emory University
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 09:40 Francisco Exposito francisco.exposito@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer Francisco Exposito Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA
  • First Name: Emily
    Last Name: Shuldiner
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Steven
    Last Name: Lopez
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Minwei
    Last Name: Wang
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Mariana
    Last Name: Do Carmo
    Affiliation: Department of Pathology, Yale School of Medicine, New Haven, CT, USA
  • First Name: Laura
    Last Name: Andrejka
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Giorgia
    Last Name: Foggetti
    Affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • First Name: Christopher
    Last Name: W. Murray
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Dimitri
    Last Name: Petrov
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Monte
    Last Name: Winslow
    Affiliation: Division of Oncology, Department of Medicine / Stanford Cancer Institute / Department of Pathology, Stanford University School of Medicine, Stanford, California
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale School of Medicine / Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 08:39 Jordan Cardenas jordan.cardenas@yale.edu 3039196514 Session 3: Immuno-oncology The combination of modified IL-18 with anti-PD1 elicits a CD4+ T cell-mediated antitumor response in MHC Class I-deficient models of non-small cell lung cancer Jordan Cardenas Yale
  • First Name: Camila
    Last Name: Robles-Oteiza
    Affiliation: Yale
  • First Name: Ting
    Last Name: Zhou
    Affiliation: Yale
  • First Name: John
    Last Name: Huck
    Affiliation: Yale
  • First Name: Paula
    Last Name: Kavathas
    Affiliation: Yale
  • First Name: Aaron
    Last Name: Ring
    Affiliation: Fred Hutch
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale
 Abstract_Submission.pdf No Approved to be a Poster Presenter Cardenas_LungSPORE_Poster.jpg
Mon, 03/11/2024 - 11:24 Junghui Koo jkoo22@emory.edu 404-323-3287 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Unlocking Immunochemotherapy Potentials for KRAS and LKB1 Mutant Lung Adenocarcinoma through FAK Inhibition and Immunotherapy with Anti-PD1 Antibody Junghui Koo Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University
  • First Name: Carol
    Last Name: Tucker-Burden
    Affiliation: Emory University
  • First Name: Melissa
    Last Name: Roy
    Affiliation: Emory University
  • First Name: Chunzi
    Last Name: Huang
    Affiliation: Emory University
  • First Name: Wei
    Last Name: Zhou
    Affiliation: Emory University
  • First Name: Melissa
    Last Name: Gilbert-Ross
    Affiliation: Emory University
  • First Name: Haian
    Last Name: Fu
    Affiliation: Emory University
  • First Name: Suresh
    Last Name: Ramalingam
    Affiliation: Emory University
  • First Name: Adam
    Last Name: Marcus
    Affiliation: Emory University
 Abstract_Submission.pdf No Approved to be a Poster Presenter